InvestorsHub Logo
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Re: None

Thursday, 07/23/2020 7:30:30 AM

Thursday, July 23, 2020 7:30:30 AM

Post# of 4
BRRGF BGBIO
in addition to COVID, Bemcentinib studied in Solid Cancer- NSCLC, GBM , etc - similar results just read out for AXL Blocker - Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500 in Platinum Resistant $BRRGF